Literature DB >> 18437523

Erectile dysfunction and Peyronie's disease in patient with retroperitoenal fibrosis.

Cem Akbal1, Yilören Tanidir, Mahir Bülent Ozgen, Ferruh Simşek.   

Abstract

OBJECTIVE: The aim of this study is to determine the sexual dysfunction in patient with retroperitoneal fibrosis (RPF) and also we explored probability of Peyronie's disease (PD) in this patient group and to compare this with the controls.
MATERIALS AND METHODS: Ten of 17 male RPF patients formed the basis of this study. Patient's age, concomitant diseases were recorded. The diagnosis of PD was based on a palpable penile plaque or acquired penile curvature. Age-matched 88 patients who were admitted to our outpatient clinic with elevated PSA level served as the control group. All patients were asked to complete the IIEF-5 questionnaire. The severity of the erectile dysfunction (ED) was classified into four categories: severe (5-7), moderate (8-16), mild (17-21), and no ED (22-25). Concomitant systemic diseases were recorded. Statistical analyses were done by the Fisher's exact test and an unpaired-sample t-test.
RESULTS: Patients with severe ED or no sexual intercourse in the study group and the control group during the study period were found to be 7 and 14, respectively. The median IIEF-5 score in RPF patients and the control group was 9.8 (min: 5 to max: 23) and 19 (min: 5 to max: 25), respectively. The differences between groups were statistically significant (P = 0.002). In particular, ED was reported in eight RPF patients (80%) which was severe in six (60%) and moderate in two (20%). ED was reported in 45 patients in the control group (51%) which was severe in 14 (15.9%), mild in 25 (28.4%), and moderate in six (6.8%). Patients with RPF had a significant tendency for severe ED compared with the control group (P = 0.0042). Two patients in the RPF group (20%) and one patient in the control group (1.1%) were found to have a penile plaque (P = 0.0279). Relative risk for developing a penile plague was found to be 0.8 in RPF.
CONCLUSION: RPF patients are found to be more prone to developing ED. Penile plaque formation was identified in RPF patients, which may be presumed to relate to the pathological changes of the RPF process, but it remains unclear that these patients demonstrate a higher incidence of plaque formation than the normal population.

Entities:  

Mesh:

Year:  2008        PMID: 18437523     DOI: 10.1007/s11255-008-9381-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  28 in total

1.  Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression.

Authors:  A I El-Sakka; H M Hassoba; R J Pillarisetty; R Dahiya; T F Lue
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

Review 2.  Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors.

Authors:  L P Dehner; C M Coffin
Journal:  Semin Diagn Pathol       Date:  1998-05       Impact factor: 3.464

Review 3.  Retroperitoneal fibrosis. A report of selected cases and a review of the literature.

Authors:  D D Buff; M B Bogin; L L Faltz
Journal:  N Y State J Med       Date:  1989-09

4.  The expression of platelet-derived growth factor and connective tissue growth factor in different types of abdominal aortic aneurysms.

Authors:  S Kanazawa; T Miyake; T Kakinuma; K Tanemoto; T Tsunoda; K Kikuchi
Journal:  J Cardiovasc Surg (Torino)       Date:  2005-06       Impact factor: 1.888

5.  Retroperitoneal fibrosis in children.

Authors:  F A Birnberg; A L Vinstein; G Gorlick; F A Lee; M S Hales
Journal:  Radiology       Date:  1982-10       Impact factor: 11.105

6.  Retroperitoneal fibrosis with disseminated vasculitis and intrahepatic sclerosing cholangitis.

Authors:  H R Hellstrom; E C Perezstable
Journal:  Am J Med       Date:  1966-02       Impact factor: 4.965

7.  Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomographic findings.

Authors:  Olivier Drieskens; Daniel Blockmans; Annick Van den Bruel; Luc Mortelmans
Journal:  Clin Nucl Med       Date:  2002-06       Impact factor: 7.794

Review 8.  Retroperitoneal fibrosis: report of 12 cases and a review of the literature.

Authors:  E F van Bommel; J van Spengler; B van der Hoven; P Kramer
Journal:  Neth J Med       Date:  1991-12       Impact factor: 1.422

9.  The clinical significance of retroperitoneal fibrosis.

Authors:  L Koep; G D Zuidema
Journal:  Surgery       Date:  1977-03       Impact factor: 3.982

10.  A retrospective review of 307 men with Peyronie's disease.

Authors:  Ates Kadioglu; Ahmet Tefekli; Bulent Erol; Tayfun Oktar; Murat Tunc; Sedat Tellaloglu
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

View more
  2 in total

Review 1.  The Natural History of Peyronie's Disease.

Authors:  Fabrizio Di Maida; Gianmartin Cito; Luca Lambertini; Francesca Valastro; Girolamo Morelli; Andrea Mari; Marco Carini; Andrea Minervini; Andrea Cocci
Journal:  World J Mens Health       Date:  2020-07-08       Impact factor: 5.400

2.  Prevalence, Risk Factors, and Erectile Dysfunction Associated With Peyronie's Disease Among Men Seeking Urological Care.

Authors:  Antonio Segundo; Sidney Glina
Journal:  Sex Med       Date:  2020-01-30       Impact factor: 2.491

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.